A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement.

Abstract

Influenza and pneumococcal disease represent a well-known burden on healthcare systems worldwide, as well as they still have an attributed morbidity and mortality, especially in elderly individuals and vulnerable populations. In the context of the ongoing pandemic of COVID-19, a series of considerations in favor of extensive influenza and pneumococcal vaccination campaign are emerging, including a possible reduction of hospital extra burden and saving of sanitary resources. In addition, recent studies have suggested that prior vaccinations towards non SARS-CoV-2 pathogens might confer some protection against COVID-19. In this paper the authors consider all factors in support of these hypotheses and provide a consensus statement to encourage influenza and pneumococcal vaccinations in targeted populations.

• Authors: Francesco Blasi, Marta Di Pasquale, Andrea Gramegna, Pierluigi Viale, Carmelo Iacobello, Andrea Gori, Mario Tumbarello, Susanna Esposito, Luca Richeldi, Matteo Bassetti
• Journal: Respiratory medicine (Respir Med) Vol. 190 Pg. 106674 (12 2021) ISSN: 1532-3064 [Electronic] England
• PMID: 34788734 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Elsevier Ltd. All rights reserved.

Chemical References

• Influenza Vaccines
• Pneumococcal Vaccines

Topics

• Adolescent
• Adult
• Aged
• Aged, 80 and over
• COVID-19 (prevention & control)
• Female
• Health Promotion
• Health Services Needs and Demand
• Humans
• Influenza Vaccines
• Influenza, Human (prevention & control)
• Italy
• Male
• Middle Aged
• Pandemics
• Pneumococcal Infections (microbiology, prevention & control)
• Pneumococcal Vaccines
• Pulmonary Medicine (organization & administration)
• Societies, Medical (organization & administration)
• Streptococcus pneumoniae
• Vaccination
• Young Adult